id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OPP-2016-0386-0009,EPA,EPA-HQ-OPP-2016-0386,Final Registration Decision for the New Active Ingredient Bacillus amyloliquefaciens strain F727,Supporting & Related Material,Decision,2018-11-16T05:00:00Z,2018,11,,,2018-12-04T20:22:04Z,,0,0,0900006482bfa53b
EPA-HQ-OPP-2016-0386-0007,EPA,EPA-HQ-OPP-2016-0386,Draft  EPA Product Label  MBI-110 EP: EPA File No. 84059-EI,Supporting & Related Material,Fact/Data Sheet,2017-09-28T04:00:00Z,2017,9,,,2017-09-29T00:48:43Z,,0,0,0900006482b0e803
EPA-HQ-OPP-2016-0386-0002,EPA,EPA-HQ-OPP-2016-0386,Public Participation for New Active Ingredient Bacillus amyloloquefaciens strain F727,Other,Public Participation,2017-09-28T04:00:00Z,2017,9,2017-09-28T04:00:00Z,2017-10-14T03:59:59Z,2017-10-14T01:03:36Z,,0,0,0900006482b8843b
EPA-HQ-OPP-2016-0386-0005,EPA,EPA-HQ-OPP-2016-0386,Ecological Review and Environmental Risk Assessment of Section 3 Registration of the New End Use Product MBl-110 EP containing Bacillus amyloliquefaciens F727. Decision # 513759.,Supporting & Related Material,Risk Assessment,2017-09-28T04:00:00Z,2017,9,,,2017-09-29T00:49:01Z,,0,0,0900006482aec46c
EPA-HQ-OPP-2016-0386-0003,EPA,EPA-HQ-OPP-2016-0386,"Review of product chemistry, manufacturing process, and acute toxicity studies for the active ingredient Bacillus amyloliquefaciens strain F727 (Submission #: 980307; Decision #: 513759; DP #: 432334)",Supporting & Related Material,Risk Assessment,2017-09-28T04:00:00Z,2017,9,,,2017-09-29T00:48:17Z,,0,0,0900006482ae2509
EPA-HQ-OPP-2016-0386-0006,EPA,EPA-HQ-OPP-2016-0386,Draft  EPA Product Label MBI-110 TGAI:  EPA File No. 84059-XX,Supporting & Related Material,Fact/Data Sheet,2017-09-28T04:00:00Z,2017,9,,,2017-09-29T00:48:52Z,,0,0,0900006482b0e802
EPA-HQ-OPP-2016-0386-0008,EPA,EPA-HQ-OPP-2016-0386,Proposed Registration Decision for the New Active Ingredient Bacillus amyloliquefaciens strain F727,Supporting & Related Material,Decision,2017-09-28T04:00:00Z,2017,9,,,2017-09-29T00:48:09Z,,0,0,0900006482b491c9
EPA-HQ-OPP-2016-0386-0004,EPA,EPA-HQ-OPP-2016-0386,"Review of product chemistry, manufacturing process, and waiver for acute toxicity studies for the end use product MBI-110 EP containing the active ingredient Bacillus amyloliquefaciens strain F727 (Submission #: 980305; Decision #: 513761; DP #: 432387)",Supporting & Related Material,Risk Assessment,2017-09-28T04:00:00Z,2017,9,,,2017-09-29T00:48:26Z,,0,0,0900006482ae29b6
EPA-HQ-OPP-2016-0386-0001,EPA,EPA-HQ-OPP-2016-0386,Pesticide Product Registrations: Applications for New Active Ingredients,Notice,,2016-08-18T04:00:00Z,2016,8,2016-08-18T04:00:00Z,2016-09-20T03:59:59Z,2016-09-11T04:26:19Z,2016-19762,0,0,0900006482182705